International Summit in Immuno-Oncology

  • The International Summit in Immuno-Oncology is a high-level scientific event bringing together global experts in cancer research, immunotherapy, and translational medicine. Held in Yerevan on October 16–18, 2025, the summit aims to lay the foundation for a world-class immuno-oncology ecosystem in Armenia through knowledge exchange, collaboration, and education.
  • Target audience: Immunologists and allergists, rheumatologists, dermatologists, oncologists, toxicologists, hematologists, pathologists, and clinical laboratory diagnostic specialists
  • Summit made possible thanks to the generous support of Fondation Bullukian, Fund for Armenian Relief, Inc. / ANSEF Yervant Terzian Initiative, and K-Pharma

Program highlights

  • Immune/Organ Interfaces in Cancer and Therapies
  • Immunology and Immunotherapy in Solid Cancers
  • Immune-Based Therapies for Hematological Malignancies

Complete program

Organizers

The summit is organized by Dr. Anna Martirosyan, Head of the Scientific Department at Santé Arménie and Translational Research Lead at the Immune Oncology Research Institute (IMMONC), and Dr. Karl Balabanian, Research Director at the Institut national de la santé et de la recherche médicale (INSERM), in collaboration with Prof. Mekinian Arsene, President of Santé Arménie; Dr. Armen Mkhitaryan, President of the Armenian Association of Clinical Pathologists and Cytologists; and Dr. Arsen Arakelyan, Director of the Institute of Molecular Biology.

Impact

the Summit brought together over 100 participants and more than 30 international and local experts in academic, translational, and clinical research. The program covered immune–organ interactions, solid tumors, and hematological malignancies through keynote lectures, scientific sessions, and short talks, fostering high-level interdisciplinary dialogue.

Beyond its strong scientific content, the Summit had a significant structural and strategic impact. Armenian clinicians and researchers were exposed to cutting-edge immunotherapy approaches, novel technologies, and current clinical trial perspectives, contributing directly to capacity building and knowledge transfer. The event also served as a powerful networking platform, identifying concrete opportunities for joint research projects, investigator-initiated studies, and international training and exchange programs between Armenian and foreign institutions.

Overall, the Summit strengthened Armenia’s position within the global immuno-oncology community and reinforced Santé Arménie Medical Academy’s role as a national hub for advanced medical education and international collaboration. It generated strong momentum for future initiatives, including the conversion of selected lectures into accredited CME and self-paced educational resources, ensuring long-term impact beyond the event itself.